insights_auto
Why is DEVA down 2,16%?
Dive Deeperchevron_right
DEVA:IST
Deva Holding AS
79,20 TRY
arrow_downward
-2,16%(-1,75) 1D
14 қаз., 18:10:00 GMT+3 · TRY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DEVA...
Open
80,80 TRY
High
80,80 TRY
Low
78,55 TRY
Mkt. cap
15,84 млрд
Avg. vol.
634,66 м.
Volume
357,36 м.
52-wk high
109,30 TRY
52-wk low
57,50 TRY
EPS
-4,21 TRY
Shares outstanding
200,02 млн
No. of employees
3 мың
Open
80,80 TRY
High
80,80 TRY
Low
78,55 TRY
Mkt. cap
15,84 млрд
Avg. vol.
634,66 м.
Volume
357,36 м.
52-wk high
109,30 TRY
52-wk low
57,50 TRY
EPS
-4,21 TRY
Shares outstanding
200,02 млн
No. of employees
3 мың
News stories
From web sources and news partners
巴士的報
·
59 минут бұрын
Oracle NetSuite Announces Launch of AI-first QuickStart: NYSE Content Update
TradingView
·
34 минут бұрын
S&P 500 Sectors Enter Powerful Historical Stretch
24/7 Wall St.
·
1 сағат бұрын
Michael Burry Says Stocks Could Peak Within 9 Months — and He’s Betting Against the Nasdaq and Chip Stocks
Profile
DEVA Holding A.Ş. is a Turkish pharmaceutical company operating since 1958. Its principal activities include the development, manufacture and marketing of human pharmaceuticals and active pharmaceutical ingredients. The company also operates in veterinary medicines, cologne, medical ampoules and food supplements.
A majority stake in the company was acquired by EastPharma in 2006. DEVA Holding is listed on Borsa Istanbul, and its chairman and chief executive officer is Philipp Haas.
As of 2025, the company had more than 675 products across 15 therapeutic areas. According to IQVIA data cited in its annual report, DEVA ranked third in the Turkish pharmaceutical market by unit sales in 2025, with a market share of 4.5%. Wikipedia
About Deva Holding AS
CEO-
Employees3,06 мың
Founded1958 ж. 22 қыр.
Headquarters-
SectorPharmaceutical industry
Websitedeva.com.tr